These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10423959)

  • 1. [Immunotherapy for MDR-TB (multi-drug resistant tuberculosis)--its feasibility].
    Tsuyuguchi I
    Kekkaku; 1999 Jun; 74(6):479-91. PubMed ID: 10423959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
    de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP
    Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunology of tuberculosis and cytokines].
    Tsuyuguchi I
    Kekkaku; 1995 May; 70(5):335-46. PubMed ID: 7783394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin.
    Liang Y; Wu X; Zhang J; Li N; Yu Q; Yang Y; Bai X; Liu C; Shi Y; Liu Q; Zhang P; Li Z
    Vaccine; 2008 Aug; 26(35):4536-40. PubMed ID: 18602439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Riddles in human tuberculous infection].
    Tsuyuguchi I
    Kekkaku; 2000 Oct; 75(10):603-9. PubMed ID: 11109776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cell-mediated immune response after lung resection surgery for MDR-TB patients.
    Park SK; Hong S; Eum SY; Lee IH; Shin DO; Cho JE; Cho S; Cho SN
    Tuberculosis (Edinb); 2011 Jul; 91(4):300-7. PubMed ID: 21514229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis.
    Cağatay T; Kiran B; Yurt S; Gülbaran Z; Kosar F; Cağatay P
    Respirology; 2005 Jun; 10(3):290-4. PubMed ID: 15955139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; Matsumoto M; McMurray DN; De la Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Hum Vaccin; 2011; 7 Suppl():60-7. PubMed ID: 21546794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.
    Okada M; Kita Y; Hashimoto S; Nakatani H; Nishimastu S; Kioka Y; Takami Y
    Hum Vaccin Immunother; 2017 Feb; 13(2):298-305. PubMed ID: 27960629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneously administered interferon-gamma for the treatment of multidrug-resistant pulmonary tuberculosis.
    Park SK; Cho S; Lee IH; Jeon DS; Hong SH; Smego RA; Cho SN
    Int J Infect Dis; 2007 Sep; 11(5):434-40. PubMed ID: 17321178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.